Activity ID
5651Expires
March 20, 2023Format Type
EnduringCME Credit
0.5Fee
30CME Provider
JAMA
Description
Diagnostic testing, NSAIDs, ACE Inhibitors, antivirals, and more. Anthony Fauci, MD from NIAID discusses latest developments in the spread and clinical management of COVID-19 and the SARS-CoV-2 virus with JAMA Editor Howard Bauchner, MD.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS MOC Part II CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Review developments in diagnostic testing, NSAIDS, ACE inhibitors, and antiviral drugs
Keywords
Coronavirus (COVID19), Global Health, Infection Control, Infectious Diseases, Public Health
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Additional Information
DOI:10.1001/jamaoto.2020.496
